Next Article in Journal
Comprehensive Profiling of Cancer-Associated Cells in the Blood of Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy to Predict Pathological Complete Response
Next Article in Special Issue
Discovery and Characteristics of a Novel Antitumor Cyclopeptide Derived from Shark
Previous Article in Journal
Structural Identifiability and Observability of Microbial Community Models
Previous Article in Special Issue
A Novel Fusion Protein System for the Production of Nanobodies and the SARS-CoV-2 Spike RBD in a Bacterial System
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Bioengineering
Volume 10
Issue 4
10.3390/bioengineering10040484
bioengineering-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

β-Glucosidase and Its Application in Bioconversion of Ginsenosides in Panax ginseng

by
Thi Ngoc Anh Tran
1,2,†,
Jin-Sung Son
1,†,
Muhammad Awais
1,
Jae-Heung Ko
2,
Deok Chun Yang
1,* and
Seok-Kyu Jung
3,*
1
Graduate School of Biotechnology, College of Life Science, Kyung Hee University, Yongin 17104, Republic of Korea
2
Department of Plant & Environmental New Resources, Kyung Hee University, Yongin 17104, Republic of Korea
3
Department of Horticulture, Kongju National University, Yesan 32439, Republic of Korea
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Bioengineering 2023, 10(4), 484; https://doi.org/10.3390/bioengineering10040484
Submission received: 28 February 2023 / Revised: 13 April 2023 / Accepted: 15 April 2023 / Published: 18 April 2023
(This article belongs to the Special Issue Biologically Active Recombinant Proteins)
Browse Figures
Versions Notes

Abstract

:
Ginsenosides are a group of bioactive compounds isolated from Panax ginseng. Conventional major ginsenosides have a long history of use in traditional medicine for both illness prevention and therapy. Bioconversion processes have the potential to create new and valuable products in pharmaceutical and biological activities, making them both critical for research and highly economic to implement. This has led to an increase in the number of studies that use major ginsenosides as a precursor to generate minor ones using β-glucosidase. Minor ginsenosides may also have useful properties but are difficult to isolate from raw ginseng because of their scarcity. Bioconversion processes have the potential to create novel minor ginsenosides from the more abundant major ginsenoside precursors in a cost-effective manner. While numerous bioconversion techniques have been developed, an increasing number of studies have reported that β-glucosidase can effectively and specifically generate minor ginsenosides. This paper summarizes the probable bioconversion mechanisms of two protopanaxadiol (PPD) and protopanaxatriol (PPT) types. Other high-efficiency and high-value bioconversion processes using complete proteins isolated from bacterial biomass or recombinant enzymes are also discussed in this article. This paper also discusses the various conversion and analysis methods and their potential applications. Overall, this paper offers theoretical and technical foundations for future studies that will be both scientifically and economically significant.

1. Introduction

Ginseng and Ginsenosides

In the Panax genus, 13 Panax species were identified (accessed on 17 April 2023 from http://www.theplantlist.org). Some Panax species have a long history of use in traditional medicine due to their composition and functionality [1]. Korean ginseng (Panax ginseng) is considered one of the most precious medicinal plants, owing to the abundance of ginsenosides of highly economical and medicinal value; however, this form of ginseng also contains additional potentially useful secondary compounds, including polysaccharides, proteins, peptides, amino acids, polyphenols, polyacetylenes, alkaloids, lipids, essential oils, phytosterols, organic acids, and terpenes [2,3,4,5,6,7]. Many such compounds, including caffeic acid, vanillic acid, coumaric acid, ferulic acid, gentisic acid, cinnamic acid, and polyactetylenes, have been reported to possess biological and pharmacological activity as antioxidants, anti-inflammatory, and/or anticancer agents [2,4,8,9,10]. P. ginseng has been utilized to investigate various pharmaceutical applications, including use as antioxidants, anticancer, anti-inflammatory, anti-hyperglycemic, treating cardiovascular and cerebrovascular diseases, and boosting the immune system [1,2,4,5].
Ginsenosides are recognized as the main bioactive components; after extraction and purification, the concentrations of total and individual ginsenosides serve as benchmarks to determine the quality of the final product. Based on the structure and derivatives, ginsenosides can be divided into three main groups: protopanaxadiol (PPD)-type, protopanaxatriol (PPT)-type, and oleanane-type. The PPD-type and PPT-type ginsenosides are classified based on the sugar moieties that are attached at the C-3, C-6, and/or C-20 positions while oleanolic acid is derived from β-amyrin [2,4,11]. In addition, the spatial distribution of ginsenosides in various parts of the ginseng plant has been a subject of some debate, with the explanation perhaps being a physiological function during tissue formation and development [12]. Furthermore, ginsenosides differ between species, and even within the same species, ginseng grown under different geographical and meteorological conditions can produce secondary compounds with variable chemical compositions and quantities [2,4,6,11,12,13].
In recent decades, the application of biotechnological techniques for ginsenoside production has become commonplace, including tissue culture to prepare biomass and stable materials for secondary compound collection, chemical elicitor treatment to increase ginsenoside synthesis in cultured ginseng cells, or adventitious roots through activation of phenylalanine ammonia lyases or the signal transducer nitric oxide. Transgenic plants are regenerated by overexpression of ginsenoside synthesis genes in plant cells, which is another efficient biotechnological way for enhancing ginsenoside yield [8]. In terms of enhancing ginsenosides yield and activities, the bioconversion of ginsenosides using microbial or recombinant enzymes is an effective method to convert major ginsenosides to minor ginsenosides that are normally present at low concentrations in fresh ginseng (Figure 1) [2]. The major ginsenosides identified to date are Rb1, Rb2, Rb3, Rc, Rd, Re, and Rg1. Through the bioconversion, the large changes are the elimination of sugar moiety at C-20, and subsequently at C-6 or C-3 of these component indicated above. Consequently, minor ginsenosides are generated and have deglycosylated forms, including Rg3, Rh2, Rh1, F2, Rg2, Rg5, F1 compound (C)-Mc1, C-Mc, C-O, C-Y, and C-K (Figure 1) [5,14,15]. The use of bioconversion to produce minor ginsenosides may help increase the pharmaceutical applications of such compounds and scientific research in this field [2,4,8,9,16].
New approaches are being developed to isolate, purify, and quantify ginsenosides on the basis of their structures and properties. The origin and type of ginseng explants have a direct impact on the extraction technique and its effectiveness. Using the polar characteristics of the solvent is the most common technique used to extract total ginsenosides. In addition to the concentration and type of solvent, the solvent/material ratio and extraction duration may influence the results of extraction and purification. Besides, several physical technologies, such as reflux systems, sonication, and rotary evaporator systems, are used independently or in combination to extract ginsenosides and optimize the resulting content [17,18,19]. For purification, many specific methods are used to increase the recovery and purity of single ginsenosides. For example, linear gradient counter-current chromatography effectively separates ginsenoside compounds extracted from the roots of Panax quinquefolium with a broad range of partition coefficients, including 11 main ginsenosides (ginsenosides Rg and Re; acetyl ginsenosides Rg1, Rb1, Rc, Rg2, and Rb3; quinquefoliums R1 and Rd; gypenoside XVII; notoginsenoside Fd) [20]. In this same species of ginseng, the use of high-performance centrifugal partition chromatography (HPCPC) combined with evaporative light-scattering detection (ELSD) was developed for the separation and purification of three compounds (Rc, Rb1, and Re) [21]. For another species of ginseng, ginsenoside F5 and F3 isomeric compounds were initially isolated and purified by reverse-phase high-performance liquid chromatography (RP-HPLC) from crude extracts of flower buds of Panax ginseng; later, the process was optimized employing a ZORBAX Eclipse XDB C-18 column and DAISOGEL C-18 column using various gradient elution systems and flow rates [22].
Bioconversion processes for ginsenosides can be evaluated quantitatively and qualitatively. Several analytical techniques can be used, such as thin layer chromatography (TLC), high performance thin layer chromatography (HPTLC), high-speed counter current chromatography (HSCCC), high performance centrifugal partition chromatography (HPCPC), gas chromatography (GC), high performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC), liquid chromatography mas spectrometry/mass spectrometry (LC-MS/MS), nuclear magnetic resonance (NMR), and two-dimensional nuclear magnetic resonance (2D-NMR). These approaches can be used separately or in combination to characterize complex natural compounds with great sensitivity, specificity, and adaptability [4,14]. The results of these analyses may contribute to future molecular biology, genomics, transcriptomics, proteomics, and metabolomics studies [12,13].

2. β-Glucosidases and Their Functions

β-glucosidase (EC 3.2.1.21) enzymes belong to the large glycoside hydrolase (GH) family of enzymes that hydrolyze the glycosidic bond. Glycoside hydrolases are classified based on amino acid sequence similarity and conserved motifs. Under this system, 180 GH families are listed in the Carbohydrate Active enZYme (CAZY) Website (http://www.cazy.org/, accessed on 14 April 2023) [9,10,12,23]. The β-glucosidases have been categorized into the following families: GH1, GH2, GH3, GH5, GH9, GH30, GH39, and GH116. The hydrolysis of terminal and non-reducing β-D-glycosyl residues by β-glucosidase releases β-D-glucose from glycosides and/or oligosaccharides. The β-glucosidase is found in all domains of living organisms and possesses several functions such as glycolipid breakdown and exogenous glycoside metabolism in animals. In plants, the function of β-glucosidase has been reported to involve processes such as cell wall lignification, cell wall β-glucan turnover, phytohormone activation, secondary metabolism, and aromatic compound release. In addition, it participates in both sides of plant–microbe and plant–insect interactions. Furthermore, biomass conversion was also described as a function of β-glucoside in microorganisms [10,23,24]. As a result, β-glucosidase can be obtained from the crude protein of most living organisms: microorganisms are the preferred source due to their high biomass potential. Moreover, to obtain significant yields of protein with high purity, protein biosynthetic genes were cloned into the target vector and placed under the control of a strong promoter before being transferred to a host with high protein production and biomass yield. The next step is to lyse the host cell and separate the target protein from other proteins depending on the structure and components of the vector carrying the gene, such as a specific binding domain or tag [15,24,25,26,27,28,29].
The application of β-glucosidase in living organisms is also garnering more interest. The β-glucosidase used in biomass conversion is often isolated from bacteria or fungi [2,6,9,10]. Isolated β-glucosidase is a valuable enzyme for the food, waste, and biofuel processing industry [2,30,31]. For example, the application of β-glucosidase activity from microorganisms isolated from food sources is receiving increasing attention due to its safe and useful features. To illustrate, β-glucosidase obtained from Lactobacillus rhamnosus isolated from fermented soymilk has great potential to enrich bioactive isoflavones for the development of functional fermented soy-based products [32].
The hydrolysis processes mediated by β-glucosidase have been used to modify flavor precursors to enhance the quality of food and beverage. Moreover, proteins with desirable properties may be targeted to increase their abundance in plants or for overproduction in transgenic microbial or plant hosts, as well as for engineering to improve their catalytic properties for flavor enhancement, stability, nutritional improvement, and to aid in plant disease prevention [2,10,33,34]. As β-glucosidase exhibits multiple activities and functions in microorganisms, plants, animals, and humans, it is anticipated to be used in many additional, as well as continued, current applications [6,10,33].

3. Bioconversion of Ginsenosides

In recent decades, numerous studies have confirmed the successful chemical, physical, and biological transformation of major ginsenosides into minor ginsenosides, resulting in increased pharmacological activity (Figure 1) [2,4,8,35]. The biologically significant transformation method utilizes a biological process that has its own unique significance in maintaining its essential activities. Biotransformation involves enzymatic hydrolysis among intestinal bacteria for selective conversion to mimic biological conditions of endophytic bacteria, edible bacteria, soil microbes, etc., and could prove useful in multiple industrial sectors. Enzymatic conversions are considered safe and commercially viable biotransformation mechanisms whose products are safe for human consumption and use [2,4,9]. Microbial transformation and recombinant enzymes are effective methods to induce high-quality for bioconversion and are undergoing extensive study, particularly with regard to post-conversion specificity of substrates and products [2,4,5,9,10].
In the ginseng industry, PPD-type and PPT-type ginsenosides from P. ginseng are successfully converted to minor ginsenosides using microbes and enzymatic methods. In ginsenosides, the sugar moiety consists of 1∼4 molecules of glycosides and common sugars are D-glucose, L-arabinopyranoside, L-arabinofuranoside, D-xylose, and/or L-rhamnose. Several enzymes, including β-glucosidase, β-xylosidase, α-L-arabinofuranosidase, and α-L-rhamnosidase, have the ability to convert ginsenoside compounds based on their characteristic sugar moieties [5,36]. Intriguingly, β-glucosidase is the most prevalent enzyme with a significant and crucial role in the generation of valuable compounds that are otherwise available in only limited quantities within extracted materials [2,10,29,32,37,38,39,40,41,42,43,44,45,46]. The mechanism of β-glucosidase can be classified as two reactions: glycoside hydrolase (GH) and glycoside transferase (GT) activities; however, GT activities and its application are not commonly exploited due to its sophisticated synthesis and the high cost of the reaction [36,47,48].
Since Rb1 is the most abundant compound in ginseng, it is frequently employed as the primary substrate and initiator in bioconversion reactions. The Rb1 molecule consists of two glucose molecules at the C3 position and two more at the C20 position; these glucose moieties are readily cleaved to produce intermediates or minor target compounds (Table 1 and Table 2) [2,6,8,9,49,50,51,52,53,54,55]. Ginsenoside bioconversion is illustrated in Figure 2.
The structures of ginsenosides used for conversion are distinguished by the type and number of sugar moieties attached to the R1, R2, and R3 sites. As noted above, PPD-type ginsenosides was classified according to positions C3 and C20, while PPT-type ginsenosides were regarded according to positions C6 and C20 [2,4,11]. Major ginsenosides are reported to have numerous health-enhancing functions, and minor ginsenosides can attack cells individually, resulting in a greater therapeutic effect [2,4,56]. Therefore, biotransformation to regenerate minor ginsenosides has been used in both research and industry. Bioconversion pathways for PPD and PPT types have been confirmed or are currently under investigation, as shown in Figure 2.
The β-glucosidase protein can be isolated from certain microorganism such as Aspergilluls niger, Stereum hirsutum JE0512, Armillaria mellea mycelia, and yeast; however, the most popular and effective approach is to employ bacteria [2,6,8,15,52,57,58,59]. Beneficial microorganisms such as fermented bacterial strains in human digestive system or naturally fermented bacteria from food are favored in bioconversion research due to their broad safety profiles [32,60].

4. β-Glucosidases Applications in Bioconversion of Ginsenosides

The β-glucosidase source may be obtained from microorganisms isolated from the soil of a ginseng farm, soybean, tea, human digestive system, kimchi, and other fermented food [14,32,61,62,63,64,65,66,67,68]. While the majority of β-glucosidases capable of ginsenosides bioconversion have been identified in bacteria, similar enzyme activity has also been found fungus, and in Aspergillus niger, Armillaria mellea, and in particular [15,28,69,70,71]. The enzyme catalyzes the hydrolysis of glycosidic bonds to terminal non-reducing residues in β-D-glucosides and oligosaccharides, releasing glucose and transforming the major ginsenosides into the corresponding minor ginsenosides. The bioconversion of ginsenosides follows different hydrolytic pathways within a multiple-step process. The hydrolytic pathway is determined by the stereospecificity of the enzyme for C-3/C-20 or C-6/C-20 linked sugars in PPD- and PPT-type ginsenosides, respectively. These β-glycosidases yield significant quantities of minor ginsenosides because they can simultaneously hydrolyze several major ginsenosides [10,16]. A simple bioconversion process of ginsenosides by a biological method that is commonly used in the laboratory is briefly described in Figure 3.
Ginseng plants have a long lifespan, ranging from four to six years, and the quality of their phytochemical compounds is low. Therefore, using ginseng as the primary material for large-scale industrial production is time-consuming and costly. Alternately, cost-effective sources of phytochemical compounds with similar structures and high biomass have been studied. For example, gypenosides isolated from plants, such as gypXVII compounds from Gynostemma pentaphyllum, are widely used for gyp LXXV or gin F2-mediated formation of CK, a well-known ginsenoside compound, exhibiting high medicinal value and various applications [31,40,56,61,63,67,72,73].
β-glucosidase not only induces bioconversion of ginsenosides, but has also been studied in the interaction between ginsenosides and protein domains that recognize the specific functions in living organisms such as structural or metabolic functions. Specifically, BaBgl3B isolated from Bifidobacterium adolescentis ATCC15703 acts as a biocatalytic tool for ginsenoside transformation and for the preparation of active glycosides and aglycones [31,74].
Several approaches to predict and identify bioconversion participants are required in order to increase applicability of the method. Such processes often involve morphological observation and screening based on the activity of a specific substrate group [44,52,58]. For example, in the genipin assay, the product of β-glucosidase hydrolysis of geniposides can react with amino acids to form a stable blue-colored compound [50]. In addition, in the esculin assay, esculin is hydrolyzed by β-glucosidase and becomes esculetin, which produces a black color in the presence of ferric ions and may act as an indicator of β-glucosidase activity. The process can be explaining line: esculin is hydrolysis by β-glucosidase and becomes the esculetin. This substrate has a black color with ferric ions [65,74,75]. Otherwise, several molecular biology tools and techniques, such as BLAST, Alignment, Illumina MiSeq sequencing, online web servers, kits, software, etc., have been used as screening methods to predict the genes responsible for high expression of target compounds. Subsequently, the dominant candidate for specificity was predicted, and their activity was confirmed by additional experiments [52,61].

5. Bioconversion of Ginsenosides by β-Glucosidase Enzymes Obtained from Microorganism

Bacteria, fungi, and yeast have been identified in the bioconversion of ginsenosides (Table 1) [8,20,66,67,76,77]. The isolation and purification of β-glucosidase are time-consuming and expensive processes. Therefore, whole-cell protein preparations are frequently used in the bioconversion of ginsenosides, despite the low enzymatic activity within the preparation and the presence of numerous other undefined factors. The β-glucosidase activity of a microorganism can be examined via ginsenoside conversion and minor ginsenoside synthesis. In this case, the bacteria were cultivated under artificial conditions using ginsenosides as a carbon source.
The activity of β-glucosidase can be manipulated during fermentation process by adjusting ginsenoside types, reaction concentration of enzyme or substrate, ion, pH, or temperature. Multiple studies have demonstrated that the optimal reaction conditions depend on the bacterial strains used and the rate of microbial growth that influence the reaction’s activity [5,9,10,14]. After induction of microbial biotransformation, the functionalities of fermented ginsenosides are assessed. Antioxidant activity is common among compounds extracted from medicinal plants. Compared to non-fermented ginseng, fermented ginseng shows greater hydroxyl radical scavenging and antioxidant activity. Minor ginsenosides derived from Rb1 or Rc, such as Rd, inhibit lipid oxidation and suppress the antioxidant defense system in various in vitro assays [2]. Moreover, increased total phenol or polyphenol content and increased antioxidant activity and biosynthesis in plants have been reported in fermented ginseng leaf and flower buds [2,78].
Anti-cancer activity, in particular, is of great interest for human applications. Anticancer effects of P. ginseng minor (but not major) ginsenoside have been demonstrated in vitro, in vivo, ex vitro, and ex vivo in both animal and human cancer cell lines [2,29,40,46,68]. Other biological activities, such as anti-inflammatory, anti-hyperglycemic, anti-diabetic, anti-aging, anti-carcinogenic, anti-fatigue, anti-pyretic regulatory effects on immunomodulation, central nervous, and cardiovascular system protection, boosting physical vitality and the promotion of DNA, RNA, and protein synthesis, also are superior in fermented compared to fresh ginseng [2,3,4,5,8,9].
Kimchi is a traditional Korean fermented food. Lactobacillus and Leuconostoc genera are the predominant microorganisms required for Kimchi’s fermentation. These bacteria hinder foodborne pathogen growth, viral activity, and the effects of lipid profiles but provide neuroprotective, antifungal, and antipoetic properties [14]. Lactobacillus genera have been demonstrated to produce Rg3 and Rg5 from Rb1, Rg1, and other organic acids [14,79]. In addition, the Dekkera anomala YAE-1 strain isolated from Mongolian fermented mare’s milk can produce β-glucosidase to convert Rb1 into Rd [59].
In addition to using ginsenosides as the primary source material, β-glucosidase can also be used to synthesize a few minor ginsenoside structures, although the mechanism is unknown. For example, after transformation using bacterial β-glucosidase in lactic acid bacteria from kimchi, two glucose molecules at C20 of Rb1 produce Rg3 and may contribute to the production of Rb3 and Rg5 from organic acids [14]. Otherwise, inoculation of ginseng extracts with Stereum hirsutum JE0512 increased the production of CK during solid-state fermentation using corn bran or cellulase from Aspergillus niger as the substrate [50].
Although human intestinal bacteria and edible food bacteria have tremendous potential for use in the food industry, their bioconversion requires an expensive medium for selection and has low yield and low productivity. In addition, neither the enzymes involved in the transformation nor the byproducts of the process are known [2,4,10,14,60].
Table
Table 1. Bioconversion of ginsenosides by whole-cell protein extraction from microorganisms.
Table 1. Bioconversion of ginsenosides by whole-cell protein extraction from microorganisms.
No.MicroorganismStrainSourcePathwayRef.
1Aspergillus nigerKCCM 11239 Rb1→Rd→F2→CK
Rb1→Rd→Rg3
Rb2→Rd
CO→F2
CY→CK
Rc→Rd
Mc1→F2
Mc→CK		[28,69,70]
2Aspergillus nigerXD101SoilRb1→CK[71]
3Armillaria melleaKACC 50013Mushroom myceliaG-Rc→C-Mc1→C-Mc
G-Rc→G-Rd→G-F2→CK		[15]
4Chryseobacterium panacisoli sp.Gsoil 183TSoilRb1→F2[80]
5Chryseobacterium ginsengiterrae sp.DCY68T Rb1→F2[81]
6Chryseobacterium yeoncheonense sp. nov.DCY67T SoilRb1→F2→CK[82]
7Dekkera anomala YAE-1YAE-1Mongolian Fermented MilkRb1→Rd[59]
8Flavobacterium panaciterraeDCY69TSoilRb1→Rd/F2[83]
9Fomitella fraxineaKACC 42289Korean Agricultural Culture CollectionRb1→Rd→F2→CK
Rc→C-Mc1→C-Mc→CK
Rb2→CO→CY		[78]
10Intrasporangium sp.GS603SoilRb1→F2
Rb1→GypXVII		[61]
11Lactobacillus mesenteroides, Pediococcus pentosaceusWiKim19
WiKim20		KimchiRb1→Rg3[14]
12Lactobacillus rossiaeDC05KimchiRb1→CK
Re→Rg2		[64]
13Lentilactobacillus buchneriURN103LKorean fermented foods Rb1→Rd→F2→CK
Rb1→Rd→Rg3		[84]
14Leuconostoc citreumLH1KimchiRb1→Rd→F2→CK[62]
15Microbacterium sp.GS514SoilRb1→Rd→Rg3[85]
16Paecilomyces Bainier sp.229Soil Rb1→Rd→Rg3[26]
17Paenibacillus puerneseDCY97TPu’er teaRb1→CK[86]
18Penicillium decumbens Rb1→GypXVII→F2→CK
Rd→F2→CK
Rg3→Rh2		[40]
19Penicillium sclerotiorum SoilRg1→F1[29]
20Weissella hellenicaDC06Fermented food (radish and cabbage)Rb1→Rg3
Rb1→Rd→F2→CK		[65]
[87]

6. Bioconversion of Ginsenoside by Recombinant β-Glucosidases

While whole-cell preparations for ginsenosides biotransformation are fairly simple to prepare and use, it is difficult to regulate off-target processes and perform glycosides hydrolysis for selective enrichment of ginsenosides. It is also difficult for the food and cosmetics industries achieve a large-scale safe approach due to challenges such as scarcity of microorganisms certified to be generally recognized as safe (GRAS), the difficulty of scaling up fermentation, the slow reaction rate, and the presence of novel end products [2,9,10]. These restrictions can be overcome by using purified recombinant β-glucosidase, which has been shown to be extremely effective and has a short reaction time to high yields. Studies using β-glucosidase recombinant enzymes have shown successful conversion of ginsenosides almost reported in GH1 and GH3 family (Table 2). Differences in amino acid sequence, structure, and interactions are among the many factors that contribute to the specificity of enzymes with substrates [5,10,24,28]. Furthermore, the specificity of β-glucosidase with regard to ginsenoside sugar moiety enables directed ginsenosides bioconversion to produce desired minor ginsenosides. This property enables hydrolytic enzymes to catalyze ginsenoside bioconversion by cleaving the glycosyl group of major ginsenosides at the exact, specified linkage point, resulting in the anticipated minor ginsenosides [10,23,74,88].
Nonetheless, the lack of acceptable hots for recombinant expression of β-glucosidase has hampered the adoption of food-grade preparations. The majority of studies of recombinant β-glucosidase gene expression and bioconversion of ginsenosides continues to employ the E. coli system as a host, which is a significant barrier to the continued implementation of recombinant enzymes in high-quality food products. New systems to achieve large-scale conversion are needed.
Several landmark studies of β-glucosidase expression in GRAS organism have hinted at its potential for enhancing the nutritional content and quality of food, pharmaceuticals, and functional foods [46,57,61,65,80]. However, there are limitations that must be overcome for the large-scale use of β-glucosidase in these ways. There are extreme circumstances, such as pH, temperature, and concentrations of enzyme and substrate, and the difficulty of isolation and purification recombinant enzyme applications [33,36,38,42,44,48,63,68,72,73,88,89]. Consequently, determination of optimal reaction condition for bioconversion to achieve the required level of production required time and cost. Regardless, recombinant enzyme models are highly applicable in the pharmaceutical, functional food, and cosmetic industries [49]. The recombinant enzyme was summarized in Table 2 with a more specific and well-characterized biotransformation pathways.
Table
Table 2. Biotransformation of ginsenosides using β-glucosidase recombinant enzymes.
Table 2. Biotransformation of ginsenosides using β-glucosidase recombinant enzymes.
No.MicroorganismGeneGene/Protein IDFamilyBioconversion PathwayRef.
1Actinosynnema mirum KACC 20028T bglAmYP_003100744GH3Rb1→GypXVII→GypLXXV/F2
Rd→F2→Rh2(S)
Re→Rh2(S)
Rg1→Rh1(S)		[72]
2Bifidobacterium adolescentis ATCC15703BaBgl1A
BaBgl3A		 Rb1→Gyp XVII
Rd→F2
Rb1→Gyp XVII and F2		[31]
3Bifidobacterium breve ATCC 15700BbBglCP006715.1
(1366947 to 1368227)		GH1Rd→F2→CK[48]
4Caldicellulosiruptor bescii DSM 6725β-glucosidaseACM59590GH1Rb1/Rb2/Rc→Rd→F2→CK[52]
5Flavobacterium chilenseBglFcSHL96941.1GH3Rb1→Rd→Rg3(S)→Rh2(S)
GypXVII →GypLXXV→CK
F2→CK
Rb2 →CO→CY
Rb3→C-Mx1→C-Mx
Rc→C-Mc1→C-Mc
Re→Rg2(S)
Rg1→Rh1(S)		[44]
6Flavobacterium johnsoniaebglF3ABQ03809GH3Rb1→Rd
GypXVII→F2		[63]
7Lactobacillus brevisBgy1BAN07577GH3GypXVII→GypLXXV→CK[56]
8Lactobacillus brevisbgy2BAN05876GH3Rb1→Rd
F2→CK		[42]
9Lactobacillus insenosidimutans EMML 3041TGST-BglL. gin-952WP_053084464GH3Rb1→Rd→Rg3(S)[68]
10Microbacterium esteraromaticumBgp1AEX88466.1GH3Re→Rg2;
Rg1→Rh1
Rb1→Rd→20(S)-Rg3		[7,88,90]
11Microbacterium esteraromaticum GS514Bgp2EU036992.1GH2Rb2→20(S)-Rg3[91]
12Microbacterium esteraromaticumbgp3JN 603821GH3Rb1→Rd→CK[74]
13Microbacterium sp.
Gsoil 167		BglG167b~WP_018187396GH3GypXVII→GypLXXV[66]
14Microbacterium testaceum ATCC 15829MT619 Re→F1
Rb1→CK		[49]
15Niabella ginsenosidivoransBglNg-767CP015772GH3Rb1→GypXVII→F2
Rd→F2
Rb2→CO
Rb3→C-Mx1
Rc→C-Mc1		[73]
16Paenibacillus mucilaginosus 3870T BglPmAEI42200GH1Rb1/Rd→F2[92]
17Pseudonocardia sp. Gsoil 1536BglPC28JX960416GH3Re→Rg2(S)
Rg1→Rh1(S)
Rb1/Rd/Rb3→Rg3(S)		[41]
18Thermotoga petrophila DSM 13995Tpexyl3
Tpebgl3		CP000702.1GH3Ginsenoside extract→20(S)-Rg3[36,89]
19Thermotoga thermarum DSM 5069TTt-BGLYP 004660190.1GH1Rb1→Rd[93]

7. Other Methods for Ginsenoside Bioconversion

As noted above, ginsenosides may be converted not only by biological methods but also by physical and chemical approaches. Many mechanisms are involved in the physical transformation of saponin composition, notably of the sugar moiety. In addition, several physical methods can successfully transform ginsenosides, namely heating, steaming, air-drying, sulfur fumigation, high hydrostatic pressure (HHP), and microwave treatment. However, with the exception of steaming, these processes have not yet been applied commercially [12,29,68,84,94]. Regarding chemical methods, acidic and alkaline hydrolysis at high temperatures, high pressure, and high pH has been used to the cleave or degrade major ginsenosides into minor ginsenosides for increased biological and pharmacological activity. Nonetheless, it is challenging to control the side reactions and implement the hydrolysis of glycosylation for selective ginsenoside enrichment [8,12,95].
In certain instances, physical and chemical methods are combined with enzyme activity to significantly boost bioconversion activities [5,84]. However, these methods are generally insufficiently selective, and involve unwanted side reactions, such as epimerization, hydration, and hydroxylation, and environmental pollutants. In addition to conversion, product optimization and purification are also essential. These highly productive and cost-effective processes rely heavily on physical and chemical techniques and are among the most prevalent approaches in biological resource conversion and utilization [53].

8. Potential Application of β-Glucosidases and Converted Ginsenosides

The process of β-glucosidase-mediated generation of minor ginsenosides from major ginsenosides illustrates the importance of ginsenoside metabolism in research and therapeutic applications [9,16,77,96]. The identification and isolation of bacterial endophytes from P. ginseng and P. notoginseng have provided novel sources of both major and minor ginsenosides, with the latter based on β-glucosidase activity [9]. The major goals in practical application are mass production and nanoparticle preparation of minor ginsenosides with large pharmacological effects [96,97]. Novel forms of minor ginsenosides may have enormous promise as therapeutic agents [96]. Functionalization or loading of minor ginsenosides onto biocompatible polymers and nanoformulations improved the solubilization and absorption of ginsenosides for clinical applications such as cancer therapy [97].
Research addressing the possible applications of ginsenosides in dairy products offered to Korean customers represents another potential application [16]. Lactic acid bacteria in dairy products can convert major ginsenosides into minor ginsenosides, and both panax ginseng and red ginseng can impact the physicochemical, sensory, ginsenoside content, and functional qualities of milk, yogurt, and fortified cheese [16]. Moreover, gram-scale ginseng extracts were employed as substrates for β-glucosidase activity in a GRAS strain that has been extensively exploited in the commercial production of food additives. In the beverage industry, β-glucosidase assists in the separation of aromatic compounds from the precursors of glucosides found in fruit juices and musts for wine making, as well as in the flavoring of tea and fruit juice [98]. These methods offer a low-risk, simple, and productive process that may be exploited to great effect in the development of recombinant enzymes for the food industry [16,49,98].
The utility of β-glucosidase has not only been documented in the food industry, but has also been documented in a wide variety of agricultural and industrial applications. For example, the geniposide present in gardenia fruits can be hydrolyzed by β-glucosidase to make genipin. Genipin combines with amino acids to produce gardenia blue, a naturally occurring blue pigment that is utilized extensively in the textile and pharmaceutical industries [99].
Interestingly, β-glucosidases may also be a cost-effective option to produce biofuels through cellulose saccharification using waste lignocellulosic residues, reducing the accumulation of this material in the natural environment [98,100]. Examples are application of the β-glucosidase produced by Moniliophthora perniciosa can or Anoxybacillus flavithermus subsp. yunnanensis E13T applied in the hydrolysis of sugarcane bagasse. Aspergillus terreus can be utilized for the hydrolysis of soybean isoflavones. The use of many thermostable and thermophilic β-glucosidases in cellulose hydrolysis is also of particular interest because the increase in temperature during the process does not impede the activity of protein, and it also favors the hydrolysis process that is carried out on the cellulose. Notably, the thermostable β-glucosidase from Aspergillus fumigatus Z5 removes phenolic compounds, so it can be used to degrade polyphenols in lignocellulosic biomass. The thermophilic β-glucosidase from Thermotoga naphthophila RUK-10 was combined with cellulase for the hydrolysis of untreated corn straw, and the conversion rate from cellulose to glucose increased by 93.5% [98,100].
Significant β-glucosidase activity has been confirmed in several bacteria genera. However, the specific metabolism and function-determining gene involved in ginsenoside biotransformation have not been studied. Nevertheless, the method for isolating protein from whole-cell bacteria is quite simple, inexpensive, and biomass is abundant. It can be utilized in the cosmetics and detergent industries, as well as for basic conversion research. These characteristics indicate the viability and ecological sustainability of microbial production of pharmaceuticals, cosmetics, and detergents (Table 1) [28,53,60,70,75,79,81,84,101]. Certain bacteria isolated from kimchi and other foods, which are confirmed to be capable of biologically converting ginsenosides through β-glucosidase activity, may be useful for the practical preparation of minor ginsenosides in a variety of industries. They may be used to improve the nutrition and quality of food, as well as industrial pharmaceuticals and functional foods [9,46,57,60,61,65,72,78,87].
The identification of the enzymes responsible for ginsenoside biosynthesis would present new avenues for efficient large-scale production of ginsenosides. Numerous studies have demonstrated the specific activity of β-glucosidase in ginsenoside biotransformation; a summary of this research is provided in Table 2. The presence of recombinant ginsenoside-transforming β-glucosidases in GRAS host trains (Corynebacterium glutamicum, Saccharomyces cerevisiae, and Lactococus lactis) has been widely exploited in the industrial synthesis of food additives [43,46,55] and may be exploited to scale up production of high-value minor ginsenosides for use in the functional foods, cosmetics, and pharmaceutical industries. This will replace the E. coli expression system, which has been shown to be the main disadvantage for animal and human applications [43,53,55]. Furthermore, combined approaches to promote efficient production of specified minor ginsenosides are of considerable benefit in various industries, particularly sustainable long-term production of biofuels [30,53]. Moreover, in order to fulfill the ever-increasing demand, efforts to increase the activity of β-glucosidases are ongoing; possible alternatives to increase the production of valuable ginsenosides and products of biotransformation include the use of synthetic biology and metabolic engineering. The eco-friendly characteristics of β-glucosidase-mediated reactions should be acknowledged as a significant advance in both manufacturing processes and industrial applications.

9. Conclusions

Ginsenosides are specialized saponins found only in Panax species with biological and pharmacological activity, engendering their application in the food and food additive industries, cosmetic industries, pharmaceutical industries, and in healthcare. In this article, we provided a comprehensive overview of the literature addressing ginsenosides and their biotransformation, with special emphasis on the role of microbial or recombinant β-glucosidases. The β-glucosidase enzymes are present in all living species and play many roles in biotransformation processes, and they are present in all living species. Increased production of minor ginsenosides, which may boost their nutritional content and activity, improving human health and quality of life, may be achieved through the use of recombinant β-glucosidases enzyme derived from a GRAS host strain. Together, these advances have led to a cost-effective and efficient industrial platform to manufacture ginsenosides for future research and increase their therapeutic applications.

Author Contributions

T.N.A.T. and J.-S.S. contributed to conception and design of the study, and wrote the first draft of the manuscript. M.A. and J.-H.K. analyzed the references and formatted the manuscript. D.C.Y. and S.-K.J. reviewed and revised the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry (IPET) through the Agri-Food Export Business Model Development Program, funded by Ministry of Agriculture, Food and Rural Affairs (MAFRA) (Project No: 320104-3).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data Availability Statements are available in section “MDPI Research Data Policies” at https://www.mdpi.com/ethics.

Conflicts of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  1. Lin, Y.; Hao, B.; Lu, Y.C.; Dong, Y.; Li, Y.; Zhang, G.H.; Yang, Z.J.; Xiang, G.S.; Liu, G.Z.; Li, X.J.; et al. PanaxGDB: A Comprehensive Platform for Panax. Front. Plant Sci. 2022, 13, 883818. [Google Scholar] [CrossRef]
  2. Eom, S.J.; Kim, K.T.; Paik, H.D. Microbial bioconversion of ginsenosides in Panax ginseng and their improved bioactivities. Food Rev. Int. 2018, 34, 698–712. [Google Scholar] [CrossRef]
  3. Yun, T.K. Brief introduction of Panax ginseng C.A. Meyer. J. Korean Med. Sci. 2001, 16, 16–18. [Google Scholar] [CrossRef]
  4. Piao, X.; Zhang, H.; Kang, J.P.; Yang, D.U.; Li, Y.; Pang, S.; Jin, Y.; Yang, D.C.; Wang, Y. Advances in saponin diversity of panax ginseng. Molecules 2020, 25, 3452. [Google Scholar] [CrossRef] [PubMed]
  5. Shin, K.C.; Oh, D.K. Classification of glycosidases that hydrolyze the specific positions and types of sugar moieties in ginsenosides. Crit. Rev. Biotechnol. 2016, 36, 1036–1049. [Google Scholar] [CrossRef]
  6. An, C.; Ma, S.; Shi, X.; Liu, C.; Ding, H.; Xue, W. Diversity and Ginsenoside Biotransformation Potential of Cultivable Endophytic Fungi Associated With Panax bipinnatifidus var. bipinnatifidus in Qinling Mountains, China. Front. Pharmacol. 2022, 13, 762862. [Google Scholar] [CrossRef] [PubMed]
  7. Huq, A.; Siraj, F.M.; Kim, Y.-J.; Yang, D.-C. Enzymatic transformation of ginseng leaf saponin by recombinant β-glucosidase (bgp1) and its efficacy in an adipocyte cell line. Biotechnol. Appl. Biochem. 2015, 63, 532–538. [Google Scholar] [CrossRef]
  8. Kim, Y.J.; Zhang, D.; Yang, D.C. Biosynthesis and biotechnological production of ginsenosides. Biotechnol. Adv. 2015, 33, 717–735. [Google Scholar] [CrossRef]
  9. Chu, L.L.; Bae, H. Bacterial endophytes from ginseng and their biotechnological application. J. Ginseng Res. 2022, 46, 1–10. [Google Scholar] [CrossRef]
  10. Cairns, J.R.K.; Esen, A. β-Glucosidases. Cell Mol. Life Sci. 2010, 67, 3389–3405. [Google Scholar] [CrossRef]
  11. Kim, D.; Kim, M.; Raña, G.S.; Han, J. Seasonal variation and possible biosynthetic pathway of ginsenosides in korean ginseng Panax ginseng meyer. Molecules 2018, 23, 1824. [Google Scholar] [CrossRef] [PubMed]
  12. Piao, X.M.; Huo, Y.; Kang, J.P.; Mathiyalagan, R.; Zhang, H. Diversity of Ginsenoside Profiles Produced by Various Processing Technologies. Molecules 2020, 25, 4390. [Google Scholar] [CrossRef] [PubMed]
  13. Ying, Z.; Awais, M.; Akter, R.; Xu, F.; Baik, S.; Jung, D.; Yang, D.C.; Kwak, G.Y.; Wenying, Y. Discrimination of Panax ginseng from counterfeits using single nucleotide polymorphism: A focused review. Front. Plant Sci. 2022, 13, 903306. [Google Scholar] [CrossRef] [PubMed]
  14. Park, B.; Hwang, H.; Lee, J.; Sohn, S.O.; Lee, S.H.; Jung, M.Y.; Lim, H.I.; Park, H.W.; Lee, J.H. Evaluation of ginsenoside bioconversion of lactic acid bacteria isolated from kimchi. J. Ginseng Res. 2017, 41, 524–530. [Google Scholar] [CrossRef]
  15. Upadhyaya, J.; Yoon, M.S.; Kim, M.J.; Ryu, N.S.; Song, Y.E.; Kim, Y.H.; Kim, M.K. Purification and characterization of a novel ginsenoside Rc-hydrolyzing β-glucosidase from Armillaria mellea mycelia. AMB Express 2016, 6, 112. [Google Scholar] [CrossRef] [PubMed]
  16. Jung, J.; Paik, N.L.H. Bioconversion, health benefits, and application of ginseng and red ginseng in dairy products. Food Sci. Biotechnol. 2017, 26, 1155–1168. [Google Scholar] [CrossRef] [PubMed]
  17. Liu, F.; Ma, N.; Xia, F.; Li, P.; He, C.; Wu, Z.; Wan, J. Preparative separation of minor saponins from Panax notoginseng leaves using biotransformation, macroporous resins, and preparative high-performance liquid chromatography. J. Ginseng Res. 2019, 43, 105–115. [Google Scholar] [CrossRef]
  18. Rebecca, M.C.; Jorge, F.S.; Ferreira, S.D.E.; Murphy, L.L. Simplified Extraction of Ginsenosides from American Ginseng (Panax quinquefolius L.) for High-Performance Liquid Chromatography—Ultraviolet Analysis. J. Agric. Food Chem. 2005, 53, 9867–9873. [Google Scholar]
  19. Lee, J.; Ha, J. Effective Purification of Ginsenosides from Cultured Wild Ginseng Roots, Red Ginseng, and White Ginseng with Macroporous Resins. J. Microbiol. Biotechnol. 2008, 18, 1789–1791. [Google Scholar] [CrossRef]
  20. Cui, L.; Yan, H.; Wang, D.; Chen, Q. An efficient isolation and purification of broad partition coefficient range ginsenosides from roots of Panax quinquefolium L. by linear gradient counter-current chromatography coupled with preparative high-performance liquid chromatography. J. Sep. Sci. 2023, 2300046. [Google Scholar] [CrossRef]
  21. Wang, J.; Bai, H.; Liu, C.; Li, L. Isolation and Purification of Ginsenosides from Plant Extract of Panax quinquefolium L. by High Performance Centrifugal Partition Chromatography Coupled with ELSD. Chromatographia 2010, 71, 267–271. [Google Scholar] [CrossRef]
  22. Li, K.; Xu, F.; Gong, X. Isolation, Purification and Quantification of Ginsenoside F5 and F3 Isomeric Compounds from Crude Extracts of Flower Buds of Panax ginseng. Molecules 2016, 21, 315. [Google Scholar] [CrossRef] [PubMed]
  23. Berrnard, H.; Gideon, D. Structure and sequence-base classification of glycoside hydrolases. Curr. Opin. Struct. Biol. 1997, 7, 637–644. [Google Scholar] [CrossRef]
  24. Henrissat, B.; Vegetales, M.; Grenoble, F. A classification of glycosyl hydrolases based sequence similarities amino acid. Biochem. J. 1991, 280, 309–316. [Google Scholar] [CrossRef] [PubMed]
  25. Liew, K.J.; Lim, L.; Woo, H.Y.; Chan, K.G.; Shamsir, M.S.; Goh, K.M. Purification and characterization of a novel GH1 beta-glucosidase from Jeotgalibacillus malaysiensis. Int. J. Biol. Macromol. 2018, 115, 1094–1102. [Google Scholar] [CrossRef]
  26. Yan, Q.; Zhou, W.; Li, X.; Feng, M.; Zhou, P. Purification method improvement and characterization of a novel ginsenoside-hydrolyzing β-glucosidase from Paecilomyces bainier sp. 229. Biosci. Biotechnol. Biochem. 2008, 72, 352–359. [Google Scholar] [CrossRef]
  27. Nallamsetty, S.; Waugh, D.S. A generic protocol for the expression and purification of recombinant proteins in Escherichia coli using a combinatorial His6-maltose binding protein fusion tag. Nat. Protoc. 2007, 2, 383–391. [Google Scholar] [CrossRef]
  28. Chang, K.H.; Jo, M.N.; Kim, K.T.; Paik, H.D. Purification and characterization of a ginsenoside Rb1-hydrolyzing β-glucosidase from Aspergillus niger KCCM 11239. Int. J. Mol. Sci. 2012, 13, 12140–12152. [Google Scholar] [CrossRef]
  29. Wei, Y.; Zhao, W.; Zhang, Q.; Zhao, Y.; Zhang, Y. Purification and characterization of a novel and unique ginsenoside Rg 1-hydrolyzing β-D-Glucosidase from Penicillium sclerotiorum. Acta Biochim. Biophys. Sin. (Shanghai) 2011, 43, 226–231. [Google Scholar] [CrossRef]
  30. Singhania, R.R.; Patel, A.K.; Pandey, A.; Ganansounou, E. Genetic modification: A tool for enhancing beta-glucosidase production for biofuel application. Bioresour. Technol. 2017, 245, 1352–1361. [Google Scholar] [CrossRef]
  31. Hu, Y.; Zhai, L.; Hong, H.; Shi, Z.; Zhao, J.; Liu, D. Study on the Biochemical Characterization and Selectivity of Three β-Glucosidases From Bifidobacterium adolescentis ATCC15703. Front. Microbiol. 2022, 13, 860014. [Google Scholar] [CrossRef] [PubMed]
  32. Hati, S.; Vij, S.; Singh, B.P.; Mandal, S. β-Glucosidase activity and bioconversion of isoflavones during fermentation of soymilk. J. Sci. Food Agric. 2015, 95, 216–220. [Google Scholar] [CrossRef]
  33. Costa, R.; Domínguez, A.; Choupina, A. Cloning and expression analysis of an endo-1,3-β-d-glucosidase from Phytophthora cinnamomi. Mol. Biol. Rep. 2020, 47, 935–942. [Google Scholar] [CrossRef] [PubMed]
  34. Kim, Y.S.; Lee, C.J.; Ma, J.Y. Enhancement of active compound, genipin, from Gardeniae Fructus using immobilized glycosyl hydrolase family 3 β-glucosidase from Lactobacillus antri. AMB Express 2017, 7, 64. [Google Scholar] [CrossRef] [PubMed]
  35. Kim, W.Y.; Kim, J.M.; Han, S.B.; Lee, S.K.; Kim, N.D.; Park, M.K.; Kim, C.K.; Park, J.H. Steaming of ginseng at high temperature enhances biological activity. J. Nat. Prod. 2000, 63, 1702–1704. [Google Scholar] [CrossRef] [PubMed]
  36. Zhang, S.; Xie, J.; Zhao, L.; Pei, J.; Su, E.; Xiao, W.; Wang, Z. Cloning, overexpression and characterization of a thermostable β-xylosidase from Thermotoga petrophila and cooperated transformation of ginsenoside extract to ginsenoside 20(S)-Rg3 with a β-glucosidase. Bioorg. Chem. 2019, 85, 159–167. [Google Scholar] [CrossRef]
  37. Amin, K.; Tranchimand, S.; Benvegnu, T.; Abdel-Razzak, Z.; Chamieh, H. Glycoside hydrolases and glycosyltransferases from hyperthermophilic archaea: Insights on their characteristics and applications in biotechnology. Biomolecules 2021, 11, 1557. [Google Scholar] [CrossRef]
  38. Wang, D.D.; Kim, Y.J.; Beak, N.I.; Mathiyalagan, R.; Wang, C.; Jin, Y.; Xu, X.Y.; Yang, D.C. Glycosyltransformation of ginsenoside Rh2 into two novel ginsenosides using recombinant glycosyltransferase from Lactobacillus rhamnosus and its in vitro applications. Ginseng Res. 2021, 45, 48–57. [Google Scholar] [CrossRef]
  39. Zhang, Y.; Yao, L.; Tang, C.; Jiang, J.; Ye, Y.; Liu, J. Qualitatively and quantitatively investigating the metabolism of 20(S)-protopanaxadiol-type ginsenosides by gut microbiota of different species. Biomed. Chromatogr. 2021, 35, e5219. [Google Scholar] [CrossRef]
  40. Kim, S.Y.; Lee, H.N.; Hong, S.J.; Kang, H.J.; Cho, J.Y.; Kim, D.; Ameer, K.; Kim, Y.M. Enhanced biotransformation of the minor ginsenosides in red ginseng extract by Penicillium decumbens β-glucosidase. Enzym. Microb. Technol. 2022, 153, 109941. [Google Scholar] [CrossRef]
  41. Du, J.; Cui, C.H.; Park, S.C.; Kim, J.K.; Yu, H.S.; Jin, F.X.; Sun, C.; Kim, S.C.; Im, W.T. Identification and characterization of a ginsenoside-transforming β-glucosidase from Pseudonocardia sp. Gsoil 1536 and its application for enhanced production of minor ginsenoside Rg2(S). PLoS ONE 2014, 9, e96914. [Google Scholar] [CrossRef] [PubMed]
  42. Zhong, F.L.; Ma, R.; Jiang, M.; Dong, W.W.; Jiang, J.; Wu, S.; Li, D.; Quan, L.H. Cloning and characterization of ginsenoside-hydrolyzing β-glucosidase from lactobacillus brevis that transforms ginsenosides Rb1 and F2 into ginsenoside Rd and compound K. J. Microbiol. Biotechnol. 2016, 26, 1661–1667. [Google Scholar] [CrossRef]
  43. Siddiqi, M.Z.; Cui, C.H.; Park, S.K.; Han, N.S.; Kim, S.C.; Im, W.T. Comparative analysis of the expression level of recombinant ginsenoside-transforming β-glucosidase in GRAS hosts and mass production of theginsenoside Rh2-Mix. PLoS ONE 2017, 12, e0176098. [Google Scholar] [CrossRef] [PubMed]
  44. Siddiqi, M.Z.; Medjebouri, S.; Liu, Q.; Park, H.Y.; Kim, G.R.; Im, W.T. Efficient Production of Various Minor Ginsenosides from PPD- and PPT-type Major Ginsenosides Using a Single Recombinant BglFc Isolated from Flavobacterium chilense. Biotechnol. Bioprocess Eng. 2021, 26, 232–246. [Google Scholar] [CrossRef]
  45. Wang, D.D.; Jin, Y.; Wang, C.; Kim, Y.J.; Zuly, E.J.P.; Baek, N.I.; Mathiyalagan, R.; Josua, M.; Yang, D.C. Rare ginsenoside Ia synthesized from F1 by cloning and overexpression of the UDP-glycosyltransferase gene from Bacillus subtilis: Synthesis, characterization, and in vitro melanogenesis inhibition activity in BL6B16 cells. J. Ginseng Res. 2018, 42, 42–49. [Google Scholar] [CrossRef]
  46. Li, L.; Lee, S.J.; Yuan, Q.P.; Im, W.T.; Kim, S.C.; Han, N.S. Production of bioactive ginsenoside Rg3(S) and compound K using recombinant Lactococcus lactis. J. Ginseng Res. 2018, 42, 412–418. [Google Scholar] [CrossRef]
  47. Li, W.N.; Fan, D. Di Biocatalytic strategies for the production of ginsenosides using glycosidase: Current state and perspectives. Appl. Microbiol. Biotechnol. 2020, 104, 3807–3823. [Google Scholar] [CrossRef]
  48. Zhang, R.; Huang, X.M.; Yan, H.J.; Liu, X.Y.; Zhou, Q.; Luo, Z.Y.; Tan, X.N.; Zhang, B.L. Highly selective production of compound k from ginsenoside rd by hydrolyzing glucose at c-3 glycoside using β-glucosidase of bifidobacterium breve atcc 15700. J. Microbiol. Biotechnol. 2019, 29, 410–418. [Google Scholar] [CrossRef]
  49. Cui, C.H.; Jeon, B.M.; Fu, Y.; Im, W.T.; Kim, S.C. High-density immobilization of a ginsenoside-transforming β-glucosidase for enhanced food-grade production of minor ginsenosides. Appl. Microbiol. Biotechnol. 2019, 103, 7003–7015. [Google Scholar] [CrossRef]
  50. Yang, W.; Zhou, J.; Harindintwali, J.D.; Yu, X. Production of minor ginsenosides by combining Stereum hirsutum and cellulase. PLoS ONE 2021, 16, e0255899. [Google Scholar] [CrossRef]
  51. Qi, G.; Ji, B.; Zhang, Y.; Huang, L.; Wang, J.; Gao, W. Microbiome-based screening and co-fermentation of rhizospheric microorganisms for highly ginsenoside Rg3 production. Microbiol. Res. 2022, 261, 127054. [Google Scholar] [CrossRef] [PubMed]
  52. Shin, K.C.; Kim, T.H.; Choi, J.H.; Oh, D.K. Complete Biotransformation of Protopanaxadiol-Type Ginsenosides to 20-O-β-Glucopyranosyl-20(S)-protopanaxadiol Using a Novel and Thermostable β-Glucosidase. J. Agric. Food Chem. 2018, 66, 2822–2829. [Google Scholar] [CrossRef] [PubMed]
  53. Han, X.; Li, W.; Ma, X.; Fan, D. Enzymatic hydrolysis and extraction of ginsenoside recovered from deep eutectic solvent-salt aqueous two-phase system. J. Biosci. Bioeng. 2020, 130, 390–396. [Google Scholar] [CrossRef]
  54. An, D.S.; Cui, C.H.; Siddiqi, M.Z.; Yu, H.S.; Jin, F.X.; Kim, S.G.; Im, W.T. Gram-scale production of ginsenoside F1 using a recombinant bacterial β-glucosidase. J. Microbiol. Biotechnol. 2017, 27, 1559–1565. [Google Scholar] [CrossRef] [PubMed]
  55. Kim, H.W.; Han, S.H.; Lee, S.W.; Choi, H.S.; Suh, H.J.; Hong, K.B. Enzymatic hydrolysis increases ginsenoside content in Korean red ginseng (Panax ginseng CA Meyer) and its biotransformation under hydrostatic pressure. J. Sci. Food Agric. 2019, 99, 6806–6813. [Google Scholar] [CrossRef] [PubMed]
  56. Zhong, F.L.; Dong, W.W.; Wu, S.; Jiang, J.; Yang, D.C.; Li, D.; Quan, L.H. Biotransformation of gypenoside XVII to compound K by a recombinant b-glucosidase. Biotechnol. Lett. 2016, 38, 1187–1193. [Google Scholar] [CrossRef] [PubMed]
  57. Yan, S.; Wei, P.C.; Chen, Q.; Chen, X.; Wang, S.C.; Li, J.R.; Gao, C. Functional and structural characterization of a β-glucosidase involved in saponin metabolism from intestinal bacteria. Biochem. Biophys. Res. Commun. 2018, 496, 1349–1356. [Google Scholar] [CrossRef]
  58. Jung, I.H.; Lee, J.H.; Hyun, Y.J.; Kim, D.H. Metabolism of ginsenoside Rb1 by human intestinal microflora and cloning of its metabolizing β-D-glucosidase from Bifidobacterium longum H-1. Biol. Pharm. Bull. 2012, 35, 573–581. [Google Scholar] [CrossRef]
  59. Renchinkhand, G.; Cho, S.H.; Park, Y.W.; Song, G.Y.; Nam, M.S. Biotransformation of major ginsenoside Rb1 to Rd by Dekkera anomala YAE-1 from mongolian fermented milk (Airag). J. Microbiol. Biotechnol. 2020, 30, 1536–1542. [Google Scholar] [CrossRef]
  60. Liang, Z.Q.; Srinivasan, S.; Kim, Y.J.; Kim, H.B.; Wang, H.T.; Yang, D.C. Lactobacillus kimchicus sp. nov., a β-glucosidase producing bacterium isolated from kimchi. Int. J. Syst. Evol. Microbiol. 2011, 61, 894–987. [Google Scholar] [CrossRef]
  61. Cheng, L.Q.; Na, J.R.; Kim, M.K.; Bang, M.H.; Yang, D.C. Microbial Conversion of Ginsenoside Rb1 to Minor Ginsenoside F2 and Gypenoside XVII by Intrasporangium sp. GS603 Isolated from Soil. J. Microbiol. 2007, 17, 1937–1943. [Google Scholar]
  62. Quan, L.H.; Piao, J.Y.; Min, I.W.; Yang, D.U.; Lee, H.N.; Yang, D.C. Bioconversion Of Ginsenoside Rb1 Into Compound K By Leuconostoc Citreum Lh1 Isolated From Kimchi. Braz. J. Microbiol. 2011, 42, 1227–1237. [Google Scholar] [CrossRef] [PubMed]
  63. Hong, H.; Cui, C.H.; Kim, J.K.; Jin, F.X.; Kim, S.C.; Im, W.T. Enzymatic biotransformation of ginsenoside Rb1 and gypenoside XVII into ginsenosides Rd and F2 by recombinant β-glucosidase from Flavobacterium johnsoniae. J. Ginseng Res. 2012, 36, 418–424. [Google Scholar] [CrossRef] [PubMed]
  64. Huq, M.A.; Kim, Y.J.; Min, J.W.; Bae, K.S.; Yang, D.C. Use of Lactobacillus rossiae DC05 for Bioconversion of the Major Ginsenosides Rb1 and Re into the Pharmacologically Active Ginsenosides C-K and Rg2. Food Sci. Biotechnol. 2014, 23, 1561–1567. [Google Scholar] [CrossRef]
  65. Huq, M.A.; Kim, Y.J.; Min, J.W.; Siraj, F.M.; Siddiqi, M.Z.; Yang, D.C. Enzymatic transformation of the major ginsenoside Rb1 to compound K by Weissella hellenica DC06. Indian J. Biotechnol. 2015, 14, 270–275. [Google Scholar]
  66. Cui, C.H.; Kim, D.J.; Jung, S.C.; Kim, S.C.; Im, W.T. Enhanced production of gypenoside LXXV using a novel ginsenoside-transforming β-glucosidase from ginseng-cultivating soil bacteria and its anti-cancer property. Molecules 2017, 22, 844. [Google Scholar] [CrossRef]
  67. Zheng, Y.; Zheng, Z.; Ming, Y.; Bai, Y.; Chen, L.; Huang, W.; Lin, M.; Liu, S.; Xiao, J.; Lin, H. Compound K producing from the enzymatic conversion of gypenoside by naringinase. Food Chem. Toxicol. 2019, 130, 253–261. [Google Scholar] [CrossRef]
  68. Siddiqi, M.Z.; Srinivasan, S.; Park, H.Y.; Im, W.T. Exploration and characterization of novel glycoside hydrolases from the whole genome of lactobacillus ginsenosidimutans and enriched production of minor ginsenoside Rg3(S) by a recombinant enzymatic process. Biomolecules 2020, 10, 288. [Google Scholar] [CrossRef]
  69. Jeong, E.B.; Kim, S.A.; Shin, K.C.; Oh, D.K. Biotransformation of protopanaxadiol-type ginsenosides in Korean ginseng extract into food-available compound K by an extracellular enzyme from aspergillus niger. J. Microbiol. Biotechnol. 2020, 30, 1560–1567. [Google Scholar] [CrossRef]
  70. Wu, X.; Qu, B.; Liu, Y.; Ren, X.; Wang, S.; Quan, Y. Highly enhanced activity and stability via affinity induced immobilization β-glucosidase from Aspergillus niger onto amino-based silica for the biotransformation of ginsenoside Rb1. J. Chromatogr. A 2021, 1653, 462388. [Google Scholar] [CrossRef]
  71. Jiang, Y.; Li, W.; Fan, D. Biotransformation of Ginsenoside Rb1 to Ginsenoside CK by Strain XD101: A Safe Bioconversion Strategy. Appl. Biochem. Biotechnol. 2021, 193, 2110–2127. [Google Scholar] [CrossRef] [PubMed]
  72. Cui, C.H.; Kim, S.C.; Im, W.T. Characterization of the ginsenoside-transforming recombinant β-glucosidase from Actinosynnema mirum and bioconversion of major ginsenosides into minor ginsenosides. Appl. Microbiol. Biotechnol. 2013, 97, 649–659. [Google Scholar] [CrossRef] [PubMed]
  73. Siddiqi, M.Z.; Hashmi, M.S.; Oh, J.M.; Chun, S.; Im, W.T. Identification of novel glycoside hydrolases via whole genome sequencing of Niabella ginsenosidivorans for production of various minor ginsenosides. 3 Biotech. 2019, 9, 258. [Google Scholar] [CrossRef] [PubMed]
  74. Quan, L.H.; Min, J.W.; Jin, Y.; Wang, C.; Kim, Y.J.; Yang, D.C. Enzymatic Biotransformation of Ginsenoside Rb1 to Compound K by Recombinant β-Glucosidase from Microbacterium esteraromaticum. Agric. Food Chem. 2012, 60, 3776–3781. [Google Scholar] [CrossRef]
  75. Sathiyaraj, S.; Kim, M.K.; Gayathri, S.; Kim, Y.J.; Jung, S.K.; In, J.G.; Yang, D.C. Microbacterium soli sp. nov., an a-glucosidase- producing bacterium isolated from soil of a ginseng field. Int. J. Syst. Evol. Microbiol. 2010, 60, 478–483. [Google Scholar] [CrossRef]
  76. Pérez, G.; Fariña, L.; Barquet, M.; Boido, E.; Gaggero, C.; Dellacassa, E.; Carrau, F. A quick screening method to identify β-glucosidase activity in native wine yeast strains: Application of Esculin Glycerol Agar (EGA) medium. World J. Microbiol. Biotechnol. 2011, 27, 47–55. [Google Scholar] [CrossRef]
  77. Fu, Y.; Yin, Z.; Wu, L.; Yin, C. Diversity of cultivable b -glycosidase-producing micro-organisms isolated from the soil of a ginseng field and their ginsenosides-hydrolysing activity. Lett. Appl. Microbiol. 2013, 58, 138–144. [Google Scholar] [CrossRef]
  78. Kim, D.W.; Lee, W.J.; Gebru, Y.A.; Upadhyaya, J.; Ko, S.R.; Kim, Y.H.; Kim, M.K. Production of minor ginsenosides c-k and c-y from naturally occurring major ginsenosides using crude β-glucosidase preparation from submerged culture of fomitella fraxinea. Molecules 2021, 26, 4820. [Google Scholar] [CrossRef]
  79. Michlmayr, H.; Schümann, C.; Barreira Braz Da Silva, N.M.; Kulbe, K.D.; Del Hierro, A.M. Isolation and basic characterization of a β-glucosidase from a strain of Lactobacillus brevis isolated from a malolactic starter culture. J. Appl. Microbiol. 2010, 108, 550–559. [Google Scholar] [CrossRef]
  80. Keum, D.H.; Yeon, J.M.; Yun, C.S.; Lee, S.Y.; Im, W.T. Chryseobacterium panacisoli sp. Nov., isolated from ginseng-cultivation soil with ginsenoside-converting activity. Int. J. Syst. Evol. Microbiol. 2021, 71, 005086. [Google Scholar] [CrossRef]
  81. Noh, J.H.; Hoang, V.A.; Kim, Y.J.; Kang, J.P.; Yang, D.C. Chryseobacterium ginsengiterrae sp. nov., with Beta-Glucosidase Activity Isolated from Soil of a Ginseng Field. Curr. Microbiol. 2017, 74, 1417–1424. [Google Scholar] [CrossRef] [PubMed]
  82. Hoang, V.A.; Kim, Y.J.; Nguyen, N.L.; Yang, D.C. Chryseobacterium yeoncheonense sp. nov., with ginsenoside converting activity isolated from soil of a ginseng field. Arch. Microbiol. 2013, 195, 463–471. [Google Scholar] [CrossRef] [PubMed]
  83. Jin, Y.; Kim, Y.J.; Hoang, V.A.; Jung, S.Y.; Nguyen, N.L.; Min, J.W.; Wang, C.; Yang, D.C. Flavobacterium panaciterrae sp. nov., a β-glucosidase producing bacterium with ginsenoside-converting activity isolated from the soil of a ginseng field. J. Gen. Appl. Microbiol. 2014, 60, 59–64. [Google Scholar] [CrossRef] [PubMed]
  84. Renchinkhand, G.; Magsar, U.; Bae, H.C.; Choi, S.H.; Nam, M.S. Identification of β-Glucosidase Activity of Lentilactobacillus buchneri URN103L and Its Potential to Convert Ginsenoside Rb1 from Panax ginseng. Foods 2022, 11, 529. [Google Scholar] [CrossRef] [PubMed]
  85. Cheng, L.Q.; Na, J.R.; Bang, M.H.; Kim, M.K.; Yang, D.C. Conversion of major ginsenoside Rb1 to 20(S)-ginsenoside Rg3 by Microbacterium sp. GS514. Phytochemistry 2008, 69, 218–224. [Google Scholar] [CrossRef]
  86. Wang, D.D.; Kim, Y.J.; Hoang, V.A.; Nguyen, N.L.; Singh, P.; Wang, C.; Yang, D.C. Paenibacillus puernese sp. nov., a β-glucosidase-producing bacterium isolated from Pu’er tea. Arch Microbiol. 2016, 198, 211–217. [Google Scholar] [CrossRef] [PubMed]
  87. Huq, M.A.; Akter, S.; Kim, Y.J.; Farh, M.E.A.; Yang, D.C. Biotransformation of major ginsenoside Rb1 to pharmacologically active ginsenoside Rg3 through fermentation byWeissella hellenica DC06 in newly developed medium Md. Bangladesh J. Sci. Ind. Res. 2016, 51, 271–278. [Google Scholar] [CrossRef]
  88. Quan, L.H.; Min, J.W.; Subramaniyam, S.; Yang, D.U.; Kim, Y.J.; Yang, D.C. Biotransformation of ginsenosides Re and Rg1 into ginsenosides Rg2 and Rh1 by recombinant b-glucosidase. Biotechnol. Lett. 2012, 34, 913–917. [Google Scholar] [CrossRef]
  89. Xie, J.; Zhao, D.; Zhao, L.; Pei, J.; Xiao, W.; Ding, G.; Wang, Z. Overexpression and characterization of a Ca2+ activated thermostable β-glucosidase with high ginsenoside Rb1 to ginsenoside 20(S)-Rg3 bioconversion productivity. J. Ind. Microbiol. Biotechnol. 2015, 42, 839–850. [Google Scholar] [CrossRef]
  90. Quan, L.H.; Min, J.W.; Yang, D.U.; Kim, Y.J.; Yang, D.C. Enzymatic biotransformation of ginsenoside Rb1 to 20(S)-Rg3 by recombinant β-glucosidase from Microbacterium esteraromaticum. Appl. Microbiol. Biotechnol. 2012, 94, 377–384. [Google Scholar] [CrossRef]
  91. Quan, L.H.; Wang, C.; Jin, Y.; Wang, T.R.; Kim, Y.J.; Yang, D.C. Isolation and characterization of novel ginsenoside-hydrolyzing glycosidase from Microbacterium esteraromaticum that transforms ginsenoside Rb2 to rare ginsenoside 20(S)-Rg3. Antonie Leeuwenhoek 2013, 104, 129–137. [Google Scholar] [CrossRef] [PubMed]
  92. Cui, C.H.; Kim, J.K.; Kim, S.C.; Im, W.T. Characterization of a ginsenoside-transforming β-glucosidase from Paenibacillus mucilaginosus and its application for enhanced production of minor ginsenoside F2. PLoS ONE 2014, 9, e85727. [Google Scholar] [CrossRef] [PubMed]
  93. Zhao, L.; Xie, J.; Zhang, X.; Cao, F.; Pei, J. Overexpression and characterization of a glucose-tolerant β-glucosidase from Thermotoga thermarum DSM 5069T with high catalytic efficiency of ginsenoside Rb1 to Rd. J. Mol. Catal. B Enzym. 2013, 95, 62–69. [Google Scholar] [CrossRef]
  94. Park, J.K.; Yang, D.U.; Arunkumar, L.; Han, Y.; Lee, S.J.; Arif, M.H.; Li, J.F.; Huo, Y.; Kang, J.P.; Hoang, V.A.; et al. Cumulative production of bioactive RG3, RG5, RK1, and CK from fermented black ginseng using novel aspergillus niger KHNT-1 strain isolated from Korean traditional food. Processes 2021, 9, 227. [Google Scholar] [CrossRef]
  95. Kim, S.A.; Shin, K.C.; Oh, D.K. Complete biotransformation of protopanaxadiol-type ginsenosides into 20-O-β-glucopyranosyl-20(S)-protopanaxadiol by permeabilized recombinant Escherichia coli cells coexpressing β-glucosidase and chaperone genes. J. Agric. Food Chem. 2019, 67, 8393–8401. [Google Scholar] [CrossRef]
  96. Ke, Y.; Huang, L.; Song, Y.; Liu, Z.; Liang, L. Preparation and pharmacological effects of minor ginsenoside nanoparticles: A review. Front. Pharmacol. 2022, 13, 974274. [Google Scholar] [CrossRef]
  97. Murugesan, M.; Mathiyalagan, R.; Boopathi, V.; Kong, B.M.; Choi, S.; Lee, C.; Yang, D.C.; Kang, S.C.; Thambi, T. Production of Minor Ginsenoside CK from Major Ginsenosides by Biotransformation and Its Advances in Targeted Delivery to Tumor Tissues Using Nanoformulations. Nanomaterials 2022, 12, 3427. [Google Scholar] [CrossRef]
  98. Srivastava, N.; Rathour, R.; Jha, S.; Pandey, K.; Srivastava, M.; Thakur, V.K.; Sengar, R.S.; Gupta, V.K.; Mazumder, P.B.; Khan, A.F.; et al. Microbial beta glucosidase enzymes: Recent advances in biomass conversation for biofuels application. Biomolecules 2019, 9, 220. [Google Scholar] [CrossRef]
  99. Yang, J.; Wang, C.; Guo, Q.; Deng, W.; Du, G.; Li, R. Isolation of the Thermostable β-Glucosidase-Secreting Strain Bacillus altitudinis JYY-02 and Its Application in the Production of Gardenia Blue. Microbiol. Spectr. 2022, 10, e01535-22. [Google Scholar] [CrossRef]
  100. Almeida, L.E.d.S.; Ribeiro, G.C.A.; Aparecida de Assis, S. β-Glucosidase produced by Moniliophthora perniciosa: Characterization and application in the hydrolysis of sugarcane bagasse. Biotechnol. Appl. Biochem. 2022, 69, 963–973. [Google Scholar] [CrossRef]
  101. Bi, Y.F.; Wang, X.Z.; Jiang, S.; Liu, J.S.; Zheng, M.Z.; Chen, P. Enzymatic transformation of ginsenosides Re, Rg1, and Rf to ginsenosides Rg2 and aglycon PPT by using β-glucosidase from Thermotoga neapolitana. Biotechnol. Lett. 2019, 41, 613–623. [Google Scholar] [CrossRef] [PubMed]
Bioengineering 10 00484 g001 550
Figure 1. Different types of ginsenosides that may be candidates for bioconversion. Ginsenosides are discriminated by the type, number of sugar moieties, and the attracted position. The major and minor ginsenosides are marked in blue and orange, respectively. The abbreviation of sugar moieties are Glc: D-glucose, Arap: L-arabinopyranoside, Araf: L-arabinofuranoside; Xyl: D-xylose; Rha: L-rhamnose.
Figure 1. Different types of ginsenosides that may be candidates for bioconversion. Ginsenosides are discriminated by the type, number of sugar moieties, and the attracted position. The major and minor ginsenosides are marked in blue and orange, respectively. The abbreviation of sugar moieties are Glc: D-glucose, Arap: L-arabinopyranoside, Araf: L-arabinofuranoside; Xyl: D-xylose; Rha: L-rhamnose.
Bioengineering 10 00484 g001
Bioengineering 10 00484 g002 550
Figure 2. Overview of ginsenoside bioconversion. The PPD and PPT pathways are indicated in the green and pink boxes, respectively. The changed sugar moieties are showed in blue. The abbreviations of sugar moieties are as follows: Glc: D-glucose, Arap: L-arabinopyranoside, Araf: L-arabinofuranoside; Xyl: D-xylose; Rha: L-rhamnose. The marked ‘’-‘’ before sugar moieties indicted the hydrolysis. The lid arrows represent confirmed conversion pathways. Interrupted arrows indicate predicted biotransformation pathways.
Figure 2. Overview of ginsenoside bioconversion. The PPD and PPT pathways are indicated in the green and pink boxes, respectively. The changed sugar moieties are showed in blue. The abbreviations of sugar moieties are as follows: Glc: D-glucose, Arap: L-arabinopyranoside, Araf: L-arabinofuranoside; Xyl: D-xylose; Rha: L-rhamnose. The marked ‘’-‘’ before sugar moieties indicted the hydrolysis. The lid arrows represent confirmed conversion pathways. Interrupted arrows indicate predicted biotransformation pathways.
Bioengineering 10 00484 g002
Bioengineering 10 00484 g003 550
Figure 3. General process of ginsenoside conversion by microorganisms and recombinant enzymes. The procedure for isolating and screening bacteria and the method for cloning the recombinant enzymes are described in the pink and blue boxes, respectively. The steps involved in protein extraction and ginsenoside bioconversion are outlined in the brown box. GOI: Gene of interest.
Figure 3. General process of ginsenoside conversion by microorganisms and recombinant enzymes. The procedure for isolating and screening bacteria and the method for cloning the recombinant enzymes are described in the pink and blue boxes, respectively. The steps involved in protein extraction and ginsenoside bioconversion are outlined in the brown box. GOI: Gene of interest.
Bioengineering 10 00484 g003
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Tran, T.N.A.; Son, J.-S.; Awais, M.; Ko, J.-H.; Yang, D.C.; Jung, S.-K. β-Glucosidase and Its Application in Bioconversion of Ginsenosides in Panax ginseng. Bioengineering 2023, 10, 484. https://doi.org/10.3390/bioengineering10040484

AMA Style

Tran TNA, Son J-S, Awais M, Ko J-H, Yang DC, Jung S-K. β-Glucosidase and Its Application in Bioconversion of Ginsenosides in Panax ginseng. Bioengineering. 2023; 10(4):484. https://doi.org/10.3390/bioengineering10040484

Chicago/Turabian Style

Tran, Thi Ngoc Anh, Jin-Sung Son, Muhammad Awais, Jae-Heung Ko, Deok Chun Yang, and Seok-Kyu Jung. 2023. "β-Glucosidase and Its Application in Bioconversion of Ginsenosides in Panax ginseng" Bioengineering 10, no. 4: 484. https://doi.org/10.3390/bioengineering10040484

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop